Chapter 106 Only Monopolies Can Enjoy Supernormal Profits



I hope that the next industrial revolution will be initiated by China, and that we can occupy the upstream of the industrial chain.

This expectation is obviously unrealistic. To be more realistic, we now have brain-computer interface technology for English-speaking countries, as well as Japanese, Korean, Arabic, and Russian-speaking countries.

The development of brain-computer interface technology for these language families will definitely exceed expectations.

In addition, the brain-computer interface prosthesis that Kechuang Bio is developing has recently been demonstrated in an official video, and the effect is very obvious. I personally compared it with similar videos from abroad, and I feel that Kechuang Bio's prosthesis is significantly more flexible.

Once brain-computer interfaces are implemented, they could support a valuation of trillions.

As for the endorphin and innovative drug pipeline, the innovative drugs are not currently being managed by Chairman Zheng personally, but are being developed by a team led by Dr. Hua Guo from Pfizer.

With financial support and no pressure regarding time and performance, I believe that Kechuang Bio can steadily build a complete drug R&D pipeline.

It is entirely possible for them to become a competitive pharmaceutical giant in the international market in the future.

Therefore, I believe that the trillion-yuan market value of Kechuang Bio is not an overvaluation, but an undervaluation.

The recent decline is due to a sell-off by funds, rather than a problem with the company's own logic or performance.

Moreover, it is quite obvious that although the stock price has been falling, foreign capital has been flowing in continuously, with northbound funds seeing a net inflow of several hundred million yuan every day.

After the release of their annual reports last year, the European asset management giant also significantly increased its holdings in science and technology innovation biotech companies in the fourth quarter.

Investors in Sci-Tech Biotech have absolutely nothing to worry about; just be prepared to grow alongside this great company.

Continue read on readnovelmtl.com


Recommendation



Comments

Please login to comment

Support Us

Donate to disable ads.

Buy Me a Coffee at ko-fi.com
Chapter List